Biosynthesis of dobutamine monoglucuronides and glucuronidation of dobutamine by recombinant human UDP-glucuronosyltransferases

Drug Metabolism and Disposition

Volumn 33, Issue 5, 2005, Pages 657-663

  Alonen, Anna ^a   Aitio, Olli ^a   Hakala, Kati ^a   Luukkanen, Leena ^a   Finel, Moshe ^a   Kostiainen, Risto ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; GLUCURONIC ACID; GLUCURONIDE; GLUCURONOSYLTRANSFERASE;

ANIMAL CELL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CATALYSIS; CELL ISOLATION; CONTROLLED STUDY; GLUCURONIDATION; HUMAN; HUMAN CELL; ISOMER; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; STRUCTURE ANALYSIS; TANDEM MASS SPECTROMETRY;

ADRENERGIC BETA-AGONISTS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOBUTAMINE; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HUMANS; ISOMERISM; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MICROSOMES, LIVER; RABBITS; RATS; RECOMBINANT PROTEINS; REFERENCE STANDARDS; SPECTROPHOTOMETRY, ULTRAVIOLET; SWINE;

ORYCTOLAGUS CUNICULUS; SUS SCROFA;

EID: 17844362183     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.104.002139     Document Type: Article

References (20)

1. Burchell B, Brierley CH, and Rance D (1995) Specificity of human UDP-glucuronosyltransferases and xenobiotic glucuronidation. Life Sci 57:1819-1831.
2. Chiu SH and Huskey SW (1998) Species differences in N-glucuronidation. Drug Metab Dispos 26:838-847.
3. Huskey SE, Miller RR, and Chiu SH (1993) N-Glucuronidation reaction. I. Tetrazole N-glucuronidation of selected angiotensin II receptor antagonists in hepatic microsomes from rats, dogs, monkeys and humans. Drug Metab Dispos 21:792-799.
4. Ishii Y, Miyoshi A, Maji D, Yamada H, and Oguri K (2004) Simultaneous expression of Guinea pig UDP-glucuronosyltransferase 2B21 (UGT2B21) and 2B22 in COS-7 cells enhances UGT2B21-catalyzed chloramphenicol glucuronidation. Drug Metab Dispos 32:1057-1060.
5. Kaivosaari S, Salonen JS, and Taskinen J (2002) N-Glucuronidation of some 4-arylalkyl-1H-imidazoles by rat, dog and human liver microsomes. Drug Metab Dispos 30:295-300.
6. Kaji H and Kume T (2005) Regioselective glucuronidation of denopamine: marked species differences and identification of human UDP- glucuronosyltransferase isoform. Drug Metab Dispos 33:403-412.
7. Keski-Hynnila H, Kurkela M, Elovaara E, Antonio L, Magdalou J, Luukkanen L, Taskinen J, and Kostiainen R (2002) Comparison of electrospray, atmospheric pressure chemical ionization, and atmospheric pressure photoionization in the identification of apomorphine, dobutamine and entacapone phase II metabolites in biological samples. Anal Chem 74:3449-3457.
8. Kurkela M, Garcia-Horsman JA, Luukkanen L, Morsky S, Taskinen J, Baumann M, Kostiainen R, Hirvonen J, and Finel M (2003) Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than the other UGTs and was purified as an active dimeric enzyme. J Biol Chem 278:3536-3544.
9. Kurkela M, Hirvonen J, Kostiainen R, and Finel M (2004) The interactions between the N-terminal and C-terminal domains of the human UDP- glucuronosyltransferases are partly isoform-specific and may involve both monomers. Biochem Pharmacol 68:2443-2450.
10. Kuuranne T, Kurkela M, Thevis M, Schanzer W, Finel M, and Kostiainen R (2003) Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases. Drug Metab Dispos 31: 1117-1124.
11. Li C, Chauret N, Trimble LA, Nicoll-Griffith DA, Silva JM, MacDonald D, Perrier H. Yergey JA, Parton T, Alexander RP, et al. (2001) Investigation of the in vitro metabolism profile of a phosphodiesterase-IV inhibitor, CDP-840: leading to structural optimization. Drug Metab Dispos 29:232-241.
12. Luukkanen L, Elovaara E, Lautala P, Taskinen J, and Vainio H (1997) Characterization of 1-hydroxypyrene as a novel marker substrate of 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase(s). Pharmacol Toxicol 80:152-158.
13. Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Belanger A, Fournel-Gigleux S, Green M, Hum DW, Iyanagi T, et al. (1997) The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255-269.
14. Murphy PJ, Williams TL, and Kau DL (1976) Disposition of dobutamine in the dog. J Pharmacol Exp Ther 199:423-431.
15. Prueksaritanont T, Subramanian R, Fang X, Ma B, Qiu Y, Lin JH, Pearson PG, and Baillie TA (2002) Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization. Drug Metab Dispos 30:505-512.
16. Ritter JK (2000) Roles of glucuronidation and UDP- glucuronosyltransferases in xenobiotic bioactivation reactions. Chem-Biol Interact 129:171-193.
17. Singh R, Chen IW, Jin L, Silva MV, Arison BH, Lin JH, and Wong BK (2001) Pharmacokinetics and metabolism of a RAS farnesyl transferase inhibitor in rats and dogs: in vitro-in vivo correlation. Drug Metab Dispos 29:1578-1587.
18. Tukey RH and Strassburg CP (2000) Human UDP-glucuronosyltransferases: metabolism, expression and disease. Annu Rev Pharmacol Toxicol 40:581-616.
19. Vashishtha SC, Hawes EM, McCann DJ, Ghosheh O, and Hogg L (2002) Quaternary ammonium-linked glucuronidation of 1-substituted imidazoles by liver microsomes: interspecies differences and structure-metabolism relationships. Drug Metab Dispos 30:1070-1076.
20. Yan M, Webster LT Jr, and Blumer JL (2002) 3-O-Methyldobutamine, a major metabolite of dobutamine in humans. Drug Metab Dispos 30:519-524.